NCT/Study#
NCT04400591 /
JCAR017-EAP-001
Expanded Access Protocol (EAP) for Patients Receiving Lisocabtagene Maraleucel that is Nonconforming for Commercial Release.
DISEASE GROUP:
Transplant
current phase:
NA
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
